-       Report 
- March 2024
-  118 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- March 2024
-  249 Pages 
- Global 
        €4468EUR$4,995USD£3,930GBP 
          -       Report 
- March 2024
-  197 Pages 
- Global 
        €4468EUR$4,995USD£3,930GBP 
          -       Report 
- March 2024
-  200 Pages 
- Global 
   From       €3712EUR$4,150USD£3,265GBP 
          -       Report 
- February 2024
-  116 Pages 
- Global 
   From       €4463EUR$4,990USD£3,926GBP 
           -       Training 
- February 2024
-  90 Minutes 
- Global 
   From       €622EUR$695USD£547GBP 
          -       Report 
- February 2024
-  16 Pages 
- Global 
               -       Report 
- January 2024
-  310 Pages 
- Global 
   From       €2504EUR$2,800USD£2,203GBP 
      €3131EUR$3,500USD£2,754GBP 
          -       Report 
- January 2024
-  250 Pages 
- Global 
        €4468EUR$4,995USD£3,930GBP 
          -       Report 
- January 2024
-  200 Pages 
- Global 
   From       €3712EUR$4,150USD£3,265GBP 
          -       Report 
- November 2023
-  366 Pages 
- Global 
        €4468EUR$4,995USD£3,930GBP 
          -       Report 
- November 2023
-  29 Pages 
- United States 
        €2236EUR$2,500USD£1,967GBP 
          -       Report 
- October 2023
-  85 Pages 
- United States 
   From       €4338EUR$4,850USD£3,816GBP 
          -       Report 
- September 2023
-  114 Pages 
- Global 
   From       €2639EUR$2,950USD£2,321GBP 
          -       Report 
- September 2023
-  87 Pages 
- Africa, Middle East 
   From       €2639EUR$2,950USD£2,321GBP 
          -       Report 
- September 2023
-  89 Pages 
   From       €2639EUR$2,950USD£2,321GBP 
          -       Report 
- September 2023
-  107 Pages 
- Asia Pacific 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- September 2023
-  112 Pages 
- Europe 
   From       €3086EUR$3,450USD£2,714GBP 
          -       Report 
- September 2023
-  101 Pages 
- North America 
   From       €2639EUR$2,950USD£2,321GBP 
          -       Report 
- September 2023
-  194 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
       
       The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically    more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less   Read more